Saying "No" To Legislated Disclosure
This article was originally published in RPM Report
Executive Summary
Pharma is being pressed on many fronts to make its promotional and educational spending public. One of the biggest threats comes from Congress, where Sen. Grassley would like to make full disclosure mandatory. Voluntary disclosure by companies and new rules on gifts by professional societies may be enough to stave off Congressional action this year.